Madrigal Pharmaceuticals (MDGL) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 87.85% |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 7.59% |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 143.95% |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 322.67% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -16.29% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 96.41% |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 14.93 Bn | - | -2.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.99% |
| Mar 31, 2026 | 4.11% |
| Dec 31, 2025 | 6.72% |
| Sep 30, 2025 | -0.48% |
| Jun 30, 2025 | 73.19% |
| Mar 31, 2025 | 55.05% |
| Dec 31, 2024 | 53.48% |
| Sep 30, 2024 | 7.96% |
| Jun 30, 2024 | -51.54% |
| Mar 31, 2024 | -74.47% |
| Dec 31, 2023 | -19.77% |
| Sep 30, 2023 | -12.57% |
| Jun 30, 2023 | -13.31% |
| Mar 31, 2023 | -25.72% |
| Dec 31, 2022 | -28.41% |
| Sep 30, 2022 | -25.19% |
| Jun 30, 2022 | -11.16% |
| Mar 31, 2022 | -0.86% |
| Dec 31, 2021 | -1.99% |
| Sep 30, 2021 | -1.07% |